Arax Advisory Partners

Position in INCY — Incyte Corp

CIK 1586767 DENVER, CO

Position in INCY

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$565,378

+$523,599 QoQ

Shares Held

6,007

+1320.1% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Arax Advisory Partners holds $6,272,368 across 181 Biotechnology names. INCY ranks #4 (9.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	EXEL	Exelixis, Inc.	18,720	$802,900
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,423	$635,426
3	TECH	BIO-TECHNE Corp	11,543	$603,237
4	INCY	Incyte Corp This page	6,007	$565,378
5	REGN	Regeneron Pharmaceuticals, Inc.	613	$473,628
6	JAZZ	Jazz Pharmaceuticals plc	2,012	$380,368
7	MESO	Mesoblast Ltd	24,425	$375,656
8	CGEN	Compugen Ltd	131,800	$280,734

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$565,378	6,007	+1320.1%	Shares	Sole	2026-05-13
2025-12-31	$41,779	423	-99.7%	Shares	Sole	2026-02-13
2025-09-30	$12,556,629	148,056	+18021.9%	Shares	Sole	2025-11-14
2025-06-30	$55,637	817	+46.7%	Shares	Sole	2025-08-12
2025-03-31	$33,726	557	-0.5%	Shares	Sole	2025-05-15
2024-12-31	$38,679	560	0.0%	Shares	Sole	2025-02-05
2024-09-30	$37,016	560	0.0%	Shares	Sole	2024-11-06
2024-06-30	$33,947	560	+2847.4%	Shares	Sole	2024-08-06
2024-03-31	$1,082	19	0.0%	Shares	Sole	2024-05-14
2023-12-31	$1,193	19	+26.7%	Shares	Sole	2024-02-06
2023-06-30	$933	15	-11.8%	Shares	Sole	2023-08-14
2023-03-31	$1,228	17	0.0%	Shares	Sole	2023-05-16
2022-12-31	$1,365	17	0.0%	Shares	Sole	2023-02-24
2022-09-30	$1,132	17	—	Shares	Sole	2022-11-03
No filing history on record for this holder in this stock.